Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms: a Double-blind, Randomized Clinical Trial

NCT05100888 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT05100888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms: a Double-blind, Randomized Clinical Trial
Lead sponsor
Semmelweis University
Phase
Not applicable
Overall status
Completed
Start date
July 11, 2022
Completion date
March 24, 2026
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, transcranial magnetic stimulation repetitive